IGF2 and Parkinson disease: Thus, IGF-II has been shown to exhibit neuroprotective actions in Alzheimer’s disease, PD and ageing conditions [24,25,28], glucocorticoid-mediated stress situations [12,13], and neuropsychiatric disorders such as schizophrenia and autism [29,30,31].